DoctorRuth Musgrove

Adjunct Researcher

Menzies Institute for Medical Research

  • Adjunct Researcher
    Menzies Institute for Medical Research
  • Menzies Institute for Medical Research, Menzies Institute for Medical Research, 443 MSP2, Hobart CBD Campuses, TAS

FUNDED PROJECTS

  • GRANT
    Glia and the progression of Parkinson's disease: Bystanders or villains?
    1 Jan 2021 - 30 Jun 2025
    People funded by this grant:
    • Dickson T,
    • Musgrove R,
    • Breadmore M
    Project Total: $534,837; There is no cure for Parkinson's disease (PD). Current treatments target only mid- to late-stage symptoms of the disease, with poor long-term efficacy and high risk of debilitating side-effects. Research by our CI team suggests that glia, the non-neuronal? cells in the central nervous system (CNS), may play a critical yet unappreciated role in the progress of PD. We have found roles for glial cells in modifying the neuronal environment and promoting a domino-like spread of abnormal alpha-synuclein (-syn), the major protein implicated in PD pathology, and in spreading functional changes through CNS networks. These data point to central roles for glial cells in propagating pathological changes between susceptible neuron populations. We will now apply novel in vitro and in vivo models to test the central hypothesis Glial cells facilitate the spread of pathology through the central nervous system in PD? to find ways to stop the disease processes earlier. Our research has two aims: AIM 1: Determine the role of glial cells in the neuron-to-neuron transfer of -syn and the spread of associated pathological changes. Using customised microfluidic cell culture platforms developed by the CI team, we will systematically interrogate the role of specific glial cell subtypes and inflammatory processes in the pathogenic mis-folding of -syn and its cell-to-cell transfer. AIM 2: Determine the role of glial cell activation on -syn transmission and the spreading of PD pathology using an in vivo model of progressive PD. We will test the hypothesis that inflammatory functions of glial cells and -syn interact to cause PD pathology to progress through CNS networks. The outcomes will determine the individual and synergistic roles of -syn and glial cells in the degeneration of PD-vulnerable neurons. This study will redefine our understanding of pathological processes in PD, thereby exposing new targets for development of better treatments. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,069,674); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Cannabinoids in cellular models of Concussion and Neurodegenerative disease
    1 Jan 2020 - 31 Dec 2020
    People funded by this grant:
    • Dickson T,
    • Musgrove R
    Project Total: $140,660; We will perform a narrative literature review relevant to project. We will test the potential of cannabinoids to treat or hinder the progression of neurodegenerative conditions and brain injury, using relevant cell-culture based models. The specific experiments will be informed and designed based on outcomes from an extensive literature review (included in our research). We will employ a number of primary cell-culture models, in which the pathogenic processes of specific neurodegenerative diseases are mimicked by alteration of the extracellular environment. These models reproduce pathological changes in neurons that occur in disease and reflect specific aspects of the disease processes, and will test the potential of cannabinoids to reverser or slow these changes. We will assess specific and disease-relevant outcomes pertaining to neuronal functions and morphology. Results will be delivered in report format. Funded by: Cyrelian ($140,660); University of Tasmania.